Related references
Note: Only part of the references are listed.Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution
Corey S. Davis et al.
PAIN MEDICINE (2020)
Acute treatment patterns in patients with migraine newly initiating a triptan
Richard B. Lipton et al.
CEPHALALGIA (2020)
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response
Steven C. Marcus et al.
CEPHALALGIA (2020)
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study
Hu Li et al.
PAIN AND THERAPY (2020)
Association of Primary Care Physician Supply With Population Mortality in the United States, 2005-2015
Sanjay Basu et al.
JAMA INTERNAL MEDICINE (2019)
Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review
Corey S. Davis et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Kathleen B. Digre
HEADACHE (2019)
Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017
Macarena C. Garcia et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017
Lyna Z. Schieber et al.
JAMA NETWORK OPEN (2019)
Impact of primary care provider density on detection and diagnosis of cutaneous melanoma
Nathaniel H. Fleming et al.
PLOS ONE (2018)
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences
Richard B. Lipton et al.
HEADACHE (2018)
Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States
J. Michael Woolley et al.
HEADACHE (2017)
New Data on Opioid Use and Prescribing in the United States
Anne Schuchat et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation
Inmaculada Hernandez et al.
STROKE (2017)
Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States
Emily W. Gower et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
Andrew Messali et al.
HEADACHE (2016)
Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis
Jason Shafrin et al.
Journal of Managed Care & Specialty Pharmacy (2016)
The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
Michael J. Marmura et al.
HEADACHE (2015)
Understanding the Rural-Urban Differences in Nonmedical Prescription Opioid Use and Abuse in the United States
Katherine M. Keyes et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2014)
Estimating a Reasonable Patient Panel Size for Primary Care Physicians With Team-Based Task Delegation
Justin Altschuler et al.
ANNALS OF FAMILY MEDICINE (2012)
Geographic Variation in Opioid Prescribing in the U.S.
Douglas C. McDonald et al.
JOURNAL OF PAIN (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data
Carl van Walraven et al.
MEDICAL CARE (2009)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)